Direct Renin Inhibitor Aliskiren Increases AQP2 Expression in Renal Collecting Ducts and Alleviates Lithium-induced Nephrogenic Diabetes Insipidus  by Lin, Y. et al.
Table 2. Comparison between patients with and without infectious
complications.
Parameters With infections
(n Z 12)
Without
infections
(n Z 11)
P value
Age, years 74.8 5.1 71.3 4.1 0.10a
Male gender, n (%) 3 (25%) 5 (45.5%) 0.40b
Body weight, kg 57.2 12.7 68.5 9.5 0.03a
Hypertension, n (%) 8 (72.7%) 9 (81.8%) 1.00b
Diabetes mellitus, n (%) 2 (16.7%) 0 (0%) 0.48b
Charlson’s Comorbidity
Index score
5.1 1.9 4.1 1.3 0.16a
Baseline serum
creatinine, umol/L
234 (94e545) 116 (57e161) 0.04c
Baseline urine creatinine
clearance, mL/min
23.3 (10.9e57.8) 48 (29e72) 0.10c
Baseline serum albumin, g/L 25 (17e32) 22 (20e24) 0.57c
Non-responder, n (%) 9 (75%) 2 (18.2%) 0.01b
Continuous data is expressed as mean standard deviation or median
(interquartile range)
aComparison by independent sample t test
bComparison by Fisher’s exact test
cComparison by Mann-Whitney test
Azathioprine 5 (21.7%)
Duration on immunosuppressant, months 13.7 (5.7e30.7)
Non-responder to immunosuppressant) 11 (47.8%)
Hospitalization, episodes (days)
Infection-related
Pneumonia 8 (34)
Urinary tract infection 4 (20)
CMV disease 2 (23)
Septicaemia of uncertain origin 4 (284)
Other infections 7 (30)
Cardiovascular / cerebrovascular events 4 (109)
Others 31 (144)
End of follow-up status, n (%)
End-stage kidney disease 4 (17.4%)
Death 5 (21.7%)
Proportion of mortality attributed to infection 3 (60%)
Continuous data expressed as mean standard deviation or median
(interquartile range); CMV Z cytomegalovirus.
)Defined as deteriorating renal function or reduction in proteinuria
<50% from baseline.
Other Specific Nephropathies S69http://dx.doi.org/10.1016/j.hkjn.2015.09.0320285
Low-dose Cyclosporine in the Treatment of Idiopathic Membranous
Nephropathy with Nephrotic Syndrome: Effectiveness and Renal Safety
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Methods: Sixty-eight IMNpatientswereenrolled inthisprospectivecohort study.
Low dose prednisone and low dose cyclosporine were prescribed on the basis of
renin-angiotensin-aldosterone (RAS) inhibition. Remission rate, relapse rateand
different renal functionchangeprofileswere recorded.Followuprenal endpoint
was defined as a decrease in eGFR >50% from baseline and a development of
eGFR< 60 ml/min/1.73 m2. Risk factors for renal injury were further analysed.
Results: A cyclosporine dose of 2.0 0.5 mg/kg/d and prednisone of
0.33 0.18 mg/kg/d were prescribed. The duration of cyclosporinetreatment was 31 17 months. The follow-up time was 46 20 months.
Twenty-nine patients (43%) achieved complete remission at 15.9 11.8
months, and 33 patients (47%) got partial remission at a median of 6 (range:
1e40) months. Twenty-six out of 62 patients (42%) with remission had relapse.
Fourteen patients (20%) developed cyclosporine-acute renal injury (CsA-ARI)
at 2.5 0.8 months, with SCr increased by > 30% during the first 3 months,
and 16 patients (24%) developed cyclosporine-chronic renal injury (CsA-CRI)
at 7.1 3.0 months with SCr increased by > 30% or eGFR decreased by >
30% during the course of the first year. Proteinuria at the time of CsA-ARI
was indentified as an independent risk factor for CsA-ARI. Lower baseline
eGFR level was identified as independent risk factor for CsA-CRI. At the end
of follow up, 16 patients (24%) reached the renal endpoint. Presence of
intimal fibrosis of artery and higher time-averaged proteinuria were identified
as independent risk factors for renal endpoint. RAS inhibition treatment
decreased the risk of renal endpoint. Neither cyclosporine cumulative usage
time nor cumulative dosage was found to be risk factors for renal injury.
Conclusion: Low dose cyclosporinewas effective in treating nephrotic patients
of IMN. Cyclosporine-associated renal injury should be an important concern
even at this low implemented dosage, especially in lower initial eGFR patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.0330305
Increased Serum Levels of Insulin-like Growth Factors in Adult Henoch-
Schoenlein Nephritis
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Objective: Insulin-like growth factor I (IGF-I) and insulin-like growth factor II
(IGF-II) are polypeptides regulating growth and cellular proliferation in
humans, and most importantly influence renal parenchyma cells and endo-
thelial cells. IGF-binding protein 3 (IGFBP-3) and IGF-binding protein 5
(IGFBP-5) modify the function of IGFs by binding to them with high-affinity.
This study aimed to investigate the role of IGF-I, IGF-II, IGFBP-3 and IGFBP-5
in adult Henoch-Schoenlein nephritis.
Methods: Serum levels of IGF-I, IGF-II, IGFBP-3 and IGFBP-5 were measured
by ELISA in 50 healthy controls (control group) and 85 adult patients with
Henoch-Schoenlein purpura (HSP group) in which 52 patients with HSPN
(HSPN group) were included. The clinical features, laboratory data and renal
pathological findings of candidates were also analyzed.
Results: Compared to the controls, plasma albumin was significantly
decreased yet serum levels of IgA and IgA/C3 were increased in the HSP
group. The serum levels of IGF-I, IGF-II, IGFBP-3 and IGFBP-5 were signifi-
cantly increased in HSP group compared to the control group (P < 0.001). Pa-
tients with HSPN had higher levels of IGF-I, IGF-IIand IGFBP-3 than HSP
patients without renal damage. In patients with HSP, the serum levels of
IGF-I, IGF-II and IGFBP-3 were related to proteinuria and plasma albumin
positively, and estimated glomerular filtration rate (eGFR) negatively by cor-
relation analysis. Logistic regression modeling confirmed that levels of IGF-I,
IGF-II and IGFBP-3 were positively related to proteinuria after adjustment
for age, albumin and eGFR. By a mean of 42.4 months of follow-up, serum
levels of IGF-I, IGF-II and IGFBP-3 were risk factors for 30% decline in eGFR.
Conclusion: The serum levels of IGF-I, IGF-II and IGFBP-3 could be new
markers to evaluate proteinuria and predict the renal outcomes in adult HSPN.http://dx.doi.org/10.1016/j.hkjn.2015.09.0350306
Direct Renin Inhibitor Aliskiren Increases AQP2 Expression in Renal
Collecting Ducts and Alleviates Lithium-induced Nephrogenic Diabetes
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The direct renin inhibitor aliskiren displays antihypertensive and antialbu-
minuric effects in humans and in animal models. Emerging evidence has
shown that aliskiren localizes and persists in medullary collecting ducts even
after treatment was discontinued. The purpose of the present study was to
S70 Other Specific Nephropathiesinvestigate whether aliskiren regulates renal aquaporin expression and
prevents lithium-induced nephrogenic diabetes insipidus. Mice injected
with aliskiren developed decreased urine output and increased urine
osmolality when compared with controls. Aliskiren significantly increased
AQP2 protein abundance in the kidney inner medulla. Immunohistochemistry
and immunofluoresence showed increased apical and intracellular labeling
of AQP2 in collecting duct principal cells of kidneys in mice treated with
aliskiren. In lithium-treated mice, aliskiren prevented urinary concentrating
defect and improved the downregulation of AQP2 protein abundance in inner
medulla of the kidney. In primary cultured rat inner medullary collecting
duct cells, aliskiren dramatically increased AQP2 protein abundance which
was significantly inhibited either by PKA inhibitor H89 or by adenylyl cyclase
inhibitor MDL12330, indicating an involvement of the cAMP signalling
pathway in mediating aliskiren-induced increased AQP2 expression. In
conclusion, the direct renin inhibitor aliskiren upregulates AQP2 protein
expression in inner medullary collecting duct principal cells and prevents
lithium-induced nephrogenic diabetes insipidus likely via PKA-cAMP
pathways.http://dx.doi.org/10.1016/j.hkjn.2015.09.0360317
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Objective: Whole genome sequencing was preceded in a familial focal and
segmental glomerulosclerosis (FSGS), then multi-step screening was made
for the data from sequencing to choose the candidate genes, provide the
theoretical basis for early diagnosis and accurate treatment of FSGS.
Methods: We chose 2 patients who had been identified as FSGS and their
mother from a family. The peripheral blood was obtained to extract DNA
from the three using the QIAquick Gel Extraction kit and then whole genome
sequencing using the Illumina HiSeq X Ten. The result were filtered against
the human databases of HAPMAP, dbSNP138 and 1000 Genome Project,
and common variations which had been reported were wiped out, then
non-synonymous variants in exonic and splicing regions were retained. Using
SIFT and Polyphen-2 software to predict the influence in protein function of
the variations and candidate genes was selected initially. And then query
OMIM, GO, KEGG pathway databases to analyze its biological characteristics
and the potential mechanism.
Results: By sequencing, we got four types of variant. The numbers of SNVs were
3038061,3132594and3037609 SNVs, thenumbers of InDelswere401259, 432406
and 398040, the numbers of SVs were 2917, 2211 and 3088, and the numbers of
CNVs were 135, 211 and 91. After multi-step screening, with 54 SNVs and 455
InDels are shared by the two patients. Combining the non-synonymous variation
from the three that patients with homozygous or compound heterozygous vari-
ation and their mother with heterozygous variation, 19 genes (KDM4A, TCF7L1,
ADRA2B, KIF1A, TOP2B, GPR115, AK9, KCNT1, WDR96, ZNF384, KRT3, DDX55,
ADCK1, TIPIN, JMJD8, STUB1, FAM83G, SLC5A10, SH3BGR) were screened out.
Conclusion: Through whole genome sequencing on an autosomal recessive
pedigree of FSGS, we got 19 genes, which are different from the previous re-
ports. It suggests that novel causative genes exist in this pedigree and more
investigation is necessary.http://dx.doi.org/10.1016/j.hkjn.2015.09.0370319
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Objective: Idiopathic membranous nephropathy (IMN) is common in elderly
patients. However, the prevalence in young adults is rising, and it is neces-
sary to study their clinical and pathological features.Methods: We retrospectively analyzed 77 young adult patients ( 35 years
old) and 160 elderly patients ( 60 years old) hospitalized in our department
between 2009 and 2014 with biopsy-proven IMN.
Results: The young adult IMN patients had a higher ratio of microscopic hema-
turia (P< 0.01) but lower ratio of kidney function deficiency (P< 0.01), hyper-
tension (P < 0.01) and diabetes (P Z 0.021) compared to elderly patients.
Meanwhile, the renal pathological changes in young adult IMN patients are
milder, as the incidence of interstitial fibrosis, infiltration of inflammatory cells
and arterioles lesions are lower than in elderly patients (P < 0.01). The mean
follow-up time was 27.3 months. Young adult group had a higher complete
remission rate (48.1% vs. 36.3%, P Z 0.083), although the total (complete
and partial) remission rate was similar (75.3% vs. 71.3%, PZ 0.510).
Conclusion: Theyoungadult IMNpatients havebetter renal functionandmilder
renal pathological lesions compared to elderly patients. All of them have a
rather good outcomebut youngadult grouphas higher complete remission rate.http://dx.doi.org/10.1016/j.hkjn.2015.09.0380322
Inhibition of Mitochondrial Complex-1 Prevents Downregulation of
NKCC2 and ENaCa in Obstructive Nephropathy
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Objective: Ureteral obstruction with subsequent hydronephrosis is a com-
mon clinical complication. Downregulation of renal sodium transporters in
obstructed kidneys could contribute to impaired urinary concentrating capa-
bility and salt waste following the release of a ureteral obstruction. This
study investigated the role of mitochondrial complex-1 inhibition in modu-
lating sodium transporters in obstructive nephropathy.
Methods: Sodium transporters were determined by qRT-PCR, Western blot-
ting, and immunohistochemistry. Mitochondrial DNA copy number (mtDNA),
mitochondrial transcription factor (mTFAM), and mitochondria-encoded
NADH dehydrogenase 1 (mtNd1) were identified. A number of known sodium
modulators, including PGE2, ET1, Ang II, natriuretic peptides (ANP, BNP, and
CNP), and nitric oxide synthases (iNOS, nNOS, and eNOS) were also examined.
Results: Following unilateral ureteral obstruction (UUO) for 7 days, sodium
transporters including NHE3, a-Na-K-ATPase, NCC, NKCC2, p-NKCC2, ENaCa,
and ENaCg were remarkably reduced by 60e90% contrasting to unaltered
expression of ENaCb, as determined by qRT-PCR,Western blotting, and immu-
nohistochemistry. This global down regulation of sodium transporters was
accompanied by striking reduction of mitochondrial DNA copy number
(mtDNA), mitochondrial transcription factor (mTFAM), and mitochondria-
encoded NADH dehydrogenase 1 (mtNd1) indicating a mitochondrial abnor-
mality. Strikingly, specific inhibition of mitochondrial complex-1 by rotenone
(500 ppm in diet) completely abolished the downregulation of NKCC2, p-
NKCC2, and ENaCa without affecting other sodium transporters. A number
of known sodiummodulators, including PGE2, ET1, Ang II, natriuretic peptides
(ANP, BNP, and CNP), and nitric oxide synthases (iNOS, nNOS, and eNOS) were
strikingly elevated by 3 to 80 folds except for nNOSin obstructed kidneys. After
rotenone administration, only BNP (+80 folds)and iNOS (+4 folds) but not
others were significantly reduced by 62% and 96%, respectively.
Conclusion: Taken together, these findings showed a substantial role of mito-
chondrial dysfunction in mediating the down regulation of NKCC2 and ENaCa
in obstructive nephropathy, possibly via iNOS-derived nitric oxide and BNP.http://dx.doi.org/10.1016/j.hkjn.2015.09.0390323
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Thy-1 Nephritis Rat
R. Yang1, X. P. Yang2, J. Suo1
1College of Medicine, Shihezi University, Shihezi, China
2Department of Nephrology, The First Affiliated Hospital, School of
Medicine, Shihezi University, Shihezi, China
Objective: The aim of this research was to study the expression of Ki67 and
mTOR in Thy-1 nephritis rat which used 1a,25-dihydroxyvitamin D3 (1,25(OH)
2D3), and its mechanism.
